OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
August 02, 2023
Manufacturer lawsuits prompt CMS to [slightly] modify pricing plan.
mRNA may be a modality whose chief advances are yet to come.
The more information shared, the smoother the approval process, says Susan J. Schniepp, distinguished fellow with Regulatory Compliance Associates.
Mapping America’s Pharmaceutical Supply (MAPS) Act aims to establish a database including key information about critical drugs so supply chain weaknesses can be identified.
The ROSS Model CDA-200 is fitted with multiple agitators for semi-continuous operation.
Sphere Fluidics’ Cyto-Mine is an automated cell line platform that is designed to enable screening of up to 40 million cells over the course of several hours.
Eurofins Genomics Blue Heron IVT mRNA synthesis service is designed to provide researchers a customizable solution.
Thermo Fisher Scientific’s Gibco OncePro Tumoroid Culture Medium Kit was specifically developed for the expansion of patient-derived tumoroids from multiple cancer indications.
Interoperability difficulties resulting from discrepancies in preferred programming languages can be resolved via statistical computing environments.
An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.